arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

PALATIN TECHNOLOGIES INC

PTN
$7.91 ▼ -0.18 (-2.29%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
17 Visible periods
31 Metrics
Absolute Benchmarks
Price Chart
36
Health
Weak
Moderately Bullish Absolute basis
auto_awesome

Analytical Summary

On an absolute basis, PALATIN TECHNOLOGIES INC shows strong fundamentals, led by Return on Invested Capital and FCF / Net Income. Watch Interest Coverage against typical quality thresholds. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap
Dividend Yield
Revenue Growth N/M
Op. Margin None
ROIC 288.7%
FCF / Share None
Trailing P/E
Price / Book
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

17-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$0.00
↓ -100.0%
Net Income Profit after all expenses
$-17.31M
↑ +41.8%
Operating Margin Operating profit as % of sales
59.3%
↑ +53.5%
FCF / Share Free cash flow per share
$-2.14
↓ -1319.1%
Long-Term Debt Long-term obligations
$332.90K
— 0.0%

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

  • Return on Invested CapitalReturn on Invested Capital of 288.7% is excellent on an absolute basis (target > 10%)
  • FCF / Net IncomeFCF / Net Income of 1.23x is good on an absolute basis (target > 1x)
warning

Bearish Risks

  • Interest CoverageInterest Coverage of -1162.06x is weak on an absolute basis (target > 5x)

Health Breakdown

Financial Health
18
Cash Quality
72

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 17 years · 65 quarters